arrow
M

Mark G. Swain

University of Calgary
H指数:75
被引数:2.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Part 2: CAR Metabolic Dysfunction-Associated Steatotic Liver Disease Working Group Recommendations for Risk Stratifying Patients With MASLD

第二部分:CAR代谢功能障碍相关脂肪性肝病工作组关于对MASLD患者进行风险分层的建议

2025-08-050
OA
Part 3: CAR Dysfunction-Associated Steatotic Liver Disease Working Group Recommendations for Ultrasound Shear Wave Elastography and MR Elastography Program Implementation, Funding, and Quality Assurance

第三部分:与CAR功能障碍相关的脂肪性肝病工作组关于剪切波超声弹性成像和磁共振弹性成像项目实施、资金保障和质量保证的建议

2025-08-050
OA
Part 1: CAR Metabolic Dysfunction-Associated Steatotic Liver Disease Working Group Guidance Statements for Detecting and Grading Hepatic Steatosis Using Ultrasound, CT, or MRI

第一部分:CAR代谢功能障碍相关脂肪性肝病工作组关于使用超声、CT或MRI检测和分级肝脂肪变性的指导声明

2025-08-050
OA
A Comprehensive Analysis of Spitzer 4.5 μm Phase Curves of Hot Jupiters
2024-12-161
OA
Loss of biochemical response at any time worsens outcomes in UDCA-treated patients with primary biliary cholangitis

在原发性胆汁性胆管炎患者中,任何时候失去生化反应都会使UDCA治疗患者的预后恶化。

2024-10-012
OAAI
Treatment response and clinical event-free survival in autoimmune hepatitis: A Canadian multicentre cohort study

自身免疫性肝炎的治疗反应和临床无事件生存率: 加拿大多中心队列研究

2024-08-013
OA